RE: (HEMO)22 May 2021 13:12
On the other hand it caused anxiety with Mint Capital being accused of trying to destroy the company with frequent loan note conversions that caused consternation among the investment community and pushed news about scientific developments with key collaborators to the back burner.
It’s over now and valuable lessons have been learned. The share price valuation is low, but there are undisclosed platforms being worked on by first class researchers in New York and thousands of patients ready for life saving treatments.